François Skowron (F Skowron)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Atopic Dermatitis

Basal Cell Carcinoma

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

François Skowron, Lucas Klepfisch, Laurent Guillaume, Janique Godeneche, Anthony Facile, Martin Gombert, Suzann Pechuzal, Jean-Luc Perrot
VEXAS syndrome following COVID-19 mRNA vaccination. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Chloé David-Ferreira, Estelle Ravni, Céline Bourgea, Elisa Cinotti, Linda Tognetti, Jean-Luc Perrot, François Skowron
Pigmented genital lesions : a prospective cross-sectional study. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Chloé David-Ferreira, Estelle Ravni, Céline Bourgea, Elisa Cinotti, Linda Tognetti, Jean-Luc Perrot, François Skowron
Pigmented genital lesions: A prospective cross-sectional study. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
François Skowron, Amélie Carbonnelle-Puscian
Prurigo pigmentosa following booster dose of COVID-19 vaccine. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Chloé David-Ferreira, Estelle Ravni, Céline Bourgea, Elisa Cinotti, Linda Tognetti, Jean-Luc Perrot, François Skowron
Pigmented genital lesions: A prospective cross-sectional study. Journal of the European Academy of Dermatology and Venereology : JEADV 37 (4) (2022)
Chloé David-Ferreira, Estelle Ravni, Céline Bourgea, Elisa Cinotti, Linda Tognetti, Jean-Luc Perrot, François Skowron
Pigmented genital lesions: A prospective cross-sectional study. Journal of the European Academy of Dermatology and Venereology : JEADV 37 (4) (2022)
L Donzier, T Deschamps, P Pralong, François Skowron
Immediate hypersensitivity reaction to ixekizumab in a patient with psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (1) (2020)